JP2007511216A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007511216A5 JP2007511216A5 JP2006538967A JP2006538967A JP2007511216A5 JP 2007511216 A5 JP2007511216 A5 JP 2007511216A5 JP 2006538967 A JP2006538967 A JP 2006538967A JP 2006538967 A JP2006538967 A JP 2006538967A JP 2007511216 A5 JP2007511216 A5 JP 2007511216A5
- Authority
- JP
- Japan
- Prior art keywords
- herpes simplex
- simplex virus
- nucleic acid
- virus according
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000700584 Simplexvirus Species 0.000 claims 43
- 108020004707 nucleic acids Proteins 0.000 claims 22
- 102000039446 nucleic acids Human genes 0.000 claims 22
- 150000007523 nucleic acids Chemical class 0.000 claims 22
- 108020004459 Small interfering RNA Proteins 0.000 claims 11
- 239000002773 nucleotide Substances 0.000 claims 11
- 125000003729 nucleotide group Chemical group 0.000 claims 11
- 230000001105 regulatory effect Effects 0.000 claims 8
- 230000000295 complement effect Effects 0.000 claims 7
- 108020004999 messenger RNA Proteins 0.000 claims 6
- 108091033319 polynucleotide Proteins 0.000 claims 6
- 102000040430 polynucleotide Human genes 0.000 claims 6
- 239000002157 polynucleotide Substances 0.000 claims 6
- 239000003550 marker Substances 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 4
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 4
- 238000011144 upstream manufacturing Methods 0.000 claims 4
- 108700020796 Oncogene Proteins 0.000 claims 3
- 230000030279 gene silencing Effects 0.000 claims 3
- 238000013518 transcription Methods 0.000 claims 3
- 230000035897 transcription Effects 0.000 claims 3
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims 2
- 101100508081 Human herpesvirus 1 (strain 17) ICP34.5 gene Proteins 0.000 claims 2
- 101150076998 ICP34.5 gene Proteins 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 101150027249 RL1 gene Proteins 0.000 claims 2
- 230000000692 anti-sense effect Effects 0.000 claims 2
- 230000001276 controlling effect Effects 0.000 claims 2
- 108091026890 Coding region Proteins 0.000 claims 1
- 102100026982 DCN1-like protein 1 Human genes 0.000 claims 1
- 241000700589 Herpes simplex virus (type 1 / strain 17) Species 0.000 claims 1
- 101000911746 Homo sapiens DCN1-like protein 1 Proteins 0.000 claims 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 231100000501 nonneurotoxic Toxicity 0.000 claims 1
- 230000000174 oncolytic effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0326798.6A GB0326798D0 (en) | 2003-11-17 | 2003-11-17 | Methods for generating mutant virus |
| US54130804P | 2004-02-03 | 2004-02-03 | |
| PCT/GB2004/004908 WO2005049846A2 (en) | 2003-11-17 | 2004-11-17 | Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007511216A JP2007511216A (ja) | 2007-05-10 |
| JP2007511216A5 true JP2007511216A5 (enExample) | 2008-01-10 |
Family
ID=34621663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538967A Pending JP2007511216A (ja) | 2003-11-17 | 2004-11-17 | 変異ウイルス |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20070003520A1 (enExample) |
| EP (1) | EP1694852B1 (enExample) |
| JP (1) | JP2007511216A (enExample) |
| WO (1) | WO2005049846A2 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9415320D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | Cancer treatment |
| US7897146B2 (en) | 2003-11-17 | 2011-03-01 | Crusade Laboratories Limited | Treatment using herpes simplex virus |
| JP2007511216A (ja) | 2003-11-17 | 2007-05-10 | クルセイド ラボラトリーズ リミテッド | 変異ウイルス |
| EP2114420B1 (en) * | 2007-02-16 | 2016-01-27 | Virttu Biologics Limited | Herpes simplex viruses and methods of viral replication |
| EP2171071B1 (en) | 2007-06-15 | 2015-08-05 | Genelux Corporation | Vaccinia virus vectors encoding a sodium-dependent transporter protein for imaging and/or treatment of tumors |
| EP2593796A4 (en) | 2010-07-16 | 2016-07-27 | Auckland Uniservices Ltd | BACTERIAL NITROREDUCTASE ENZYMES AND METHOD THEREFOR |
| WO2012106529A1 (en) * | 2011-02-02 | 2012-08-09 | The Trustees Of Princeton University | Jagged1 as a marker and therapeutic target for breast cancer bone metastasis |
| US9447156B2 (en) | 2011-05-17 | 2016-09-20 | St. Jude Children's Research Hospital | Methods and compositions for inhibiting neddylation of proteins |
| US8859256B2 (en) | 2011-10-05 | 2014-10-14 | Genelux Corporation | Method for detecting replication or colonization of a biological therapeutic |
| WO2013138522A2 (en) | 2012-03-16 | 2013-09-19 | Genelux Corporation | Methods for assessing effectiveness and monitoring oncolytic virus treatment |
| WO2013158265A1 (en) | 2012-04-20 | 2013-10-24 | Genelux Corporation | Imaging methods for oncolytic virus therapy |
| EP2662117A1 (en) | 2012-05-11 | 2013-11-13 | Virttu Biologics Limited | Herpes Simplex Virus for the treatment of liver cancer |
| US20140140959A1 (en) | 2012-10-05 | 2014-05-22 | Aladar A. Szalay | Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes |
| US10238700B2 (en) | 2014-01-02 | 2019-03-26 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
| KR102122463B1 (ko) | 2014-10-14 | 2020-06-15 | 할로자임, 아이엔씨 | 아데노신 디아미네이즈-2(ada2)의 조성물, 이의 변이체 및 이를 사용하는 방법 |
| GB201520345D0 (en) * | 2015-11-18 | 2015-12-30 | Virttu Biolog Ltd | Herpes simplex viruses |
| WO2017181148A2 (en) | 2016-04-15 | 2017-10-19 | Alpine Immune Sciences, Inc. | Icos ligand variant immunomodulatory proteins and uses thereof |
| IL310729A (en) | 2016-04-15 | 2024-04-01 | Alpine Immune Sciences Inc | Cd80 variant immunomodulatory proteins and uses thereof |
| US11471488B2 (en) | 2016-07-28 | 2022-10-18 | Alpine Immune Sciences, Inc. | CD155 variant immunomodulatory proteins and uses thereof |
| EP3491013A1 (en) | 2016-07-28 | 2019-06-05 | Alpine Immune Sciences, Inc. | Cd155 variant immunomodulatory proteins and uses thereof |
| US11834490B2 (en) | 2016-07-28 | 2023-12-05 | Alpine Immune Sciences, Inc. | CD112 variant immunomodulatory proteins and uses thereof |
| EP3872180A1 (en) | 2016-10-20 | 2021-09-01 | Alpine Immune Sciences, Inc. | Secretable variant immunomodulatory proteins and engineered cell therapy |
| CN110869052A (zh) | 2016-12-23 | 2020-03-06 | 维图生物制剂公司 | 癌症的治疗 |
| EP3580341A4 (en) | 2017-02-09 | 2020-11-04 | Indapta Therapeutics, Inc. | Engineered natural killer (nk) cells and compositions and methods thereof |
| WO2018170021A1 (en) | 2017-03-16 | 2018-09-20 | Alpine Immune Sciences, Inc. | Pd-l1 variant immunomodulatory proteins and uses thereof |
| US11732022B2 (en) | 2017-03-16 | 2023-08-22 | Alpine Immune Sciences, Inc. | PD-L2 variant immunomodulatory proteins and uses thereof |
| IL268781B2 (en) | 2017-03-16 | 2025-09-01 | Alpine Immune Sciences Inc | Cd80 variant immunomodulatory proteins and uses thereof |
| EA202090974A1 (ru) | 2017-10-18 | 2020-08-05 | Элпайн Иммьюн Сайенсиз, Инк. | Вариантные иммуномодулирующие белки лиганда icos и сопутствующие композиции и способы |
| WO2019136179A1 (en) | 2018-01-03 | 2019-07-11 | Alpine Immune Sciences, Inc. | Multi-domain immunomodulatory proteins and methods of use thereof |
| WO2019213305A1 (en) | 2018-05-01 | 2019-11-07 | Albert Einstein College Of Medicine | HSV-2-DELTA-gD VACCINES AND METHODS FOR THEIR PRODUCTION AND USE |
| CA3177467A1 (en) | 2018-06-04 | 2019-12-12 | Calidi Biotherapeutics, Inc. | Cell-based vehicles for potentiation of viral therapy |
| US11505782B2 (en) | 2018-06-04 | 2022-11-22 | Calidi Biotherapeutics, Inc. | Cell-based vehicles for potentiation of viral therapy |
| WO2019241758A1 (en) | 2018-06-15 | 2019-12-19 | Alpine Immune Sciences, Inc. | Pd-1 variant immunomodulatory proteins and uses thereof |
| EP3844276A2 (en) | 2018-08-28 | 2021-07-07 | Actym Therapeutics, Inc. | Engineered immunostimulatory bacterial strains and uses thereof |
| JP7329593B2 (ja) | 2018-11-06 | 2023-08-18 | カリディ・バイオセラピューティクス・インコーポレイテッド | 細胞媒介性腫瘍溶解性ウイルス治療のための増強された系 |
| CN113891934A (zh) | 2018-11-21 | 2022-01-04 | 因达普塔治疗公司 | 扩增天然杀伤（nk）细胞子集的方法以及相关组合物和方法 |
| CA3120868A1 (en) | 2018-11-30 | 2020-06-04 | Alpine Immune Sciences, Inc. | Cd86 variant immunomodulatory proteins and uses thereof |
| CA3176660A1 (en) | 2019-02-27 | 2020-09-03 | Actym Therapeutics, Inc. | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment |
| US12024709B2 (en) | 2019-02-27 | 2024-07-02 | Actym Therapeutics, Inc. | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment |
| EP4139439A1 (en) | 2020-04-22 | 2023-03-01 | Indapta Therapeutics, Inc. | Natural killer (nk) cell compositions and methods for generating same |
| TW202241479A (zh) | 2020-12-30 | 2022-11-01 | 美商安迅生物製藥公司 | 遞送外來抗原之溶瘤病毒及表現靶向外來抗原之嵌合受體之經工程化免疫細胞之組合療法 |
| WO2025129492A1 (zh) * | 2023-12-20 | 2025-06-26 | 中国科学院深圳先进技术研究院 | 一种减毒单纯疱疹病毒在制备神经环路逆向示踪工具病毒中的应用 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965138A (en) | 1985-09-06 | 1999-10-12 | Syntro Corporation | Recombinant chimeric virus and uses thereof |
| WO1989012684A1 (en) | 1988-06-24 | 1989-12-28 | National Research Development Corporation | Fowlpox virus non-essential regions |
| DK0538496T3 (da) | 1991-08-26 | 2004-02-23 | Baxter Healthcare Sa | Rekombinant fjerkrækoppevirus med intakt FPV tk-gen |
| EP0722493A1 (en) | 1993-07-27 | 1996-07-24 | THE WISTAR INSTITUTE OF ANATOMY & BIOLOGY | Modified dna virus vectors and uses therefor |
| US6025127A (en) * | 1994-01-14 | 2000-02-15 | The Johns Hopkins University School Of Medicine | Nucleic acid mutation detection in histologic tissue |
| GB9415320D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | Cancer treatment |
| EP0753581A1 (en) | 1995-07-10 | 1997-01-15 | Immuno Ag | Improved recombinant eukaryotic cytoplasmic viruses, method for their production and their use as vaccines |
| ZA966287B (en) | 1995-07-27 | 1998-03-09 | American Cyanamid Co | Avirulent herpetic viruses useful as tumoricidal agents and vaccines. |
| EP0856062A2 (en) | 1995-10-19 | 1998-08-05 | St. Jude Children's Research Hospital | Herpesvirus vectors and their uses |
| WO1997026904A1 (en) | 1996-01-25 | 1997-07-31 | Medical Research Council | Treatment of non-neuronal cancer using hsv mutant |
| US5998174A (en) | 1997-05-12 | 1999-12-07 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Multigene vectors |
| GB9801930D0 (en) | 1998-01-29 | 1998-03-25 | Univ London | Mutant herpes simplex viruses and uses thereof |
| US5922576A (en) * | 1998-02-27 | 1999-07-13 | The John Hopkins University | Simplified system for generating recombinant adenoviruses |
| US6573090B1 (en) * | 1998-12-09 | 2003-06-03 | The General Hospital Corporation | Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors |
| AU3391200A (en) | 1999-03-04 | 2000-09-21 | Corixa Corporation | Compositions and methods for breast cancer therapy and diagnosis |
| US6428968B1 (en) * | 1999-03-15 | 2002-08-06 | The Trustees Of The University Of Pennsylvania | Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject |
| MXPA02002142A (es) | 1999-08-31 | 2003-04-10 | Gen Hospital Corp | Promotor especifico de la celula y/o especifico del tumor, que re-selecciona como objetivo la expresion del gen gamma 35.5 de herpes. |
| GB9930418D0 (en) | 1999-12-22 | 2000-02-16 | Neurovex Ltd | Replication incompetent herpes virus vectors |
| AU2695101A (en) * | 2000-01-21 | 2001-07-31 | Biovex Ltd | Virus strains |
| US20030073099A1 (en) * | 2000-04-18 | 2003-04-17 | Tang Y. Tom | Novel nucleic acids and polypeptides |
| JP2004526421A (ja) * | 2000-11-09 | 2004-09-02 | セニックス バイオサイエンス ゲー エム ベー ハー | 真核細胞分裂遺伝子並びに増殖疾患の診断および処置におけるそれらの使用 |
| AU2002230895A8 (en) * | 2000-12-21 | 2007-06-21 | Myriad Genetics Inc | Protein-protein interactions |
| CA2452653A1 (en) * | 2001-07-17 | 2003-01-30 | Anne Josephine Milner | Silencing of gene expression by sirna |
| US7348418B2 (en) * | 2002-02-08 | 2008-03-25 | Memorial Sloan-Kettering Cancer Center | Carcinoma-related genes and polypeptides and methods of use thereof |
| GB0203285D0 (en) * | 2002-02-12 | 2002-03-27 | Brown Susanne M | An herpes simplex virus complex |
| US7288529B2 (en) * | 2003-04-24 | 2007-10-30 | New York University | ALK protein tyrosine kinase, cells and methods embodying and using same |
| WO2007026146A1 (en) | 2005-08-30 | 2007-03-08 | Crusade Laboratories Limited | Treatment using herpes simplex virus |
| JP2007511216A (ja) | 2003-11-17 | 2007-05-10 | クルセイド ラボラトリーズ リミテッド | 変異ウイルス |
| GB0326798D0 (en) | 2003-11-17 | 2003-12-24 | Crusade Lab Ltd | Methods for generating mutant virus |
| EP2016182B8 (en) | 2006-05-11 | 2015-09-02 | Virttu Biologics Limited | Mutant hsv, materials and methods for generation of mutant hsv |
| EP2114420B1 (en) | 2007-02-16 | 2016-01-27 | Virttu Biologics Limited | Herpes simplex viruses and methods of viral replication |
| GB0714578D0 (en) | 2007-07-26 | 2007-09-05 | Crusade Lab Ltd | Viruses |
-
2004
- 2004-11-17 JP JP2006538967A patent/JP2007511216A/ja active Pending
- 2004-11-17 US US10/579,622 patent/US20070003520A1/en not_active Abandoned
- 2004-11-17 EP EP04798619A patent/EP1694852B1/en not_active Expired - Lifetime
- 2004-11-17 WO PCT/GB2004/004908 patent/WO2005049846A2/en not_active Ceased
-
2009
- 2009-05-06 US US12/436,382 patent/US8530437B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007511216A5 (enExample) | ||
| US10653799B2 (en) | Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein | |
| WO2000046355B1 (en) | Telomerase reverse transcriptase transcriptional regulatory sequences | |
| JP2007511215A5 (enExample) | ||
| JP2022163182A5 (enExample) | ||
| JP5690814B2 (ja) | 抗原特異的な免疫応答を高めるための組成物及び方法 | |
| JP2010519904A5 (enExample) | ||
| CN114207134A (zh) | 工程化的mRNA序列及其用途 | |
| EP3778892A1 (en) | Novel small activating rna | |
| JPWO2020163365A5 (enExample) | ||
| JP2006507807A5 (enExample) | ||
| CA2532460A1 (en) | Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof | |
| CN103484462B (zh) | Survivin启动子调控CD基因的重组腺病毒载体构建及其应用 | |
| WO2002095041A1 (en) | Virus high effectively expressing the tumor interferon and specifically reproduction in tumor cells and the use thereof | |
| JP2009535031A5 (enExample) | ||
| CN112513281B (zh) | 抗肿瘤组合物 | |
| KR20140018560A (ko) | Ｈｐｖ 감염과 관련된 암의 치료용 조성물 | |
| Song et al. | Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme | |
| JP2008503569A5 (enExample) | ||
| KR20030081338A (ko) | 종양 세포에서 고효율로 종양 세포 혈관형성 억제인자를발현시키는 바이러스 및 이의 용도 | |
| JPWO2020118115A5 (enExample) | ||
| CN114703186B (zh) | 肿瘤特异性启动子及其应用 | |
| WO2019000148A1 (zh) | 一种人ABCB6基因的siRNA及其应用 | |
| KR100357054B1 (ko) | 종양 특이증식 재조합 아데노바이러스 및 그를 이용하여 종양세포만을 특이적으로 형질전환시키는 방법 | |
| US20250179497A1 (en) | Use of dinucleotide repeat rnas to treat cancer |